SABRINA CORDERO: Open Payments
NPI 1578929022 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,322 in 81 payments from 20 companies in 2025. Trend: 2023 $1,449 · 2024 $1,766 · 2025 $2,322
Food & beverage: $2,322
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 9 | $333 |
| Incyte Corporation | 6 | $242 |
| GENZYME CORPORATION | 6 | $220 |
| AstraZeneca Pharmaceuticals LP | 8 | $210 |
| SOBI, INC | 7 | $162 |
| Novartis Pharmaceuticals Corporation | 8 | $161 |
| Daiichi Sankyo Inc. | 7 | $159 |
| PharmaEssentia USA Corporation | 7 | $152 |
| Merck Sharp & Dohme LLC | 5 | $140 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
Products named: MONOFERRIC, JAKAFI, ENHERTU, INJECTAFER, BESREMI, Doptelet, Fabhalta, AYVAKIT.
Industry payments across FL — which companies pay providers there.
